Idocview
Vendor:
First CVE: Feb 16, 2024 · Active for 2 years
1
Total CVEs
Bottom 1%
1.0
Avg CVEs / Year
Bottom 1%
9.8
Avg CVSS
Higher Avg CVSS than 88% of tracked products
0.0%
KEV Rate
Bottom 1%
Trends Over Time
The number and severity of CVEs published that impact Idocview over time
Volume of CVEsAvg CVSS Base Score
First CVE
Feb 16, 2024
2 years ago
Most Recent CVE
Feb 16, 2024
892 days ago
CVE Severity & Scoring
Idocview1 CVEs
100%
All CVEs352,785 CVEs
45%
40%
11%
Critical
Attack Vector
Local0 (0.0%)
Network1 (100.0%)
Unknown0 (0.0%)
Physical0 (0.0%)
Adjacent Network0 (0.0%)
Attack Complexity
Low1 (100.0%)
High0 (0.0%)
Unknown0 (0.0%)
User Interaction
None1 (100.0%)
Unknown0 (0.0%)
Required0 (0.0%)
Privileges Required
Low0 (0.0%)
High0 (0.0%)
None1 (100.0%)
Unknown0 (0.0%)
Top CVEs
Signals from CVEs in this product scope (1 CVEs).
1 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2024-24377CRITICAL An issue in idocv v.14.1.3_20231228 allows a remote attacker to execute arbitrary code and obtain sensitive information via a crafted script. | Feb 16, 2024 | 9.8 | 26 | NO | NO |
Exploit Exposure
Signals from CVEs in this product scope (1 CVEs).
CISA KEV
0 CVEs
0.0% of CVEs· Bottom 1%
Metasploit
0 CVEs
0.0% of CVEs· Bottom 1%
Nuclei
0 CVEs
0.0% of CVEs· Bottom 1%
ExploitDB
0 CVEs
0.0% of CVEs· Bottom 1%
Social Chatter
Signals from CVEs in this product scope (1 CVEs).
Media Mentions
Signals from CVEs in this product scope (1 CVEs).
Top CNAs Publishing CVEs For Idocview
Top CWEs
Versions
No cataloged versions.